Lung Diseases, Obstructive

• GSK Investigational Site — Fukuoka, Japan
• GSK Investigational Site — Fukuoka, Japan
• GSK Investigational Site — Fukushima, Japan
• GSK Investigational Site — Gunma, Japan

• GSK Investigational Site — Winston-Salem, North Carolina, United States
• GSK Investigational Site — Pittsburgh, Pennsylvania, United States
• GSK Investigational Site — Tallinn, Estonia
• GSK Investigational Site — Tartu, Estonia

Not specified

• GSK Investigational Site — Wellington, New Zealand

• University of Kansas Medical Center — Kansas City, Kansas, United States
• Children's Mercy Hospital — Kansas City, Missouri, United States

• GSK Investigational Site — Gaungzhou, Guangdong, China
• GSK Investigational Site — Guangzhou, Guangdong, China
• GSK Investigational Site — Zhanjiang, Guangdong, China
• GSK Investigational Site — Nanning, Guangxi, China

• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Rolling Hills Estates, California, United States
• GSK Investigational Site — Sacramento, California, United States
• GSK Investigational Site — San Jose, California, United States

• Almirall Investigational Sites#1 — Ghent, Belgium
• Almirall Investigational Sites#3 — Berlin, Germany
• Almirall Investigational Sites#4 — Berlin, Germany
• Almirall Investigational Sites#9 — Berlin, Germany

• GSK Investigational Site — Fukuoka, Japan
• GSK Investigational Site — Gunma, Japan
• GSK Investigational Site — Hiroshima, Japan
• GSK Investigational Site — Hiroshima, Japan

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Huntington Beach, California, United States